Background: Blood pressure (BP) control is one of the most important treatments of
Autosomal dominant polycystic kidney disease (ADPKD). The comparative efficacy of …

Discussion Haemodialysis patients and patients with other types of bleeding tendency are
prone to spontaneous and traumatic subdural and intracerebral haematoma. Moreover, the …

Hypertensive patients with autosomal dominant polycystic kidney disease (ADPKD) have a
faster progression to end-stage renal disease (ESRD) than their normotensive counterparts …

In a previous communication, about 10 years ago, we presented two patients with
erythrocytosis associated with renal tubular acidosis type‐I (RTA‐I). At that time their work …

Abstract In the Ramipril Efficacy in Nephropathy study, ramipril decreased the rate of GFR
decline (ΔGFR) and progression to end-stage renal disease (ESRD) in 352 patients with …

Background: It is uncertain how often patients with autosomal dominant polycystic kidney
disease (ADPKD) develop kidney stones. Objective: To review English-language studies …

Cardiovascular (CV) complications are the major cause of death in autosomal-dominant
polycystic kidney disease (ADPKD) patients. Hypertension is common in these patients even …

The prevalence of nephrolithiasis is considerably greater in patients with autosomal
dominant polycystic kidney disease (ADPKD) than in the general population. We evaluated …

Background Autosomal dominant polycystic kidney disease (ADPKD) leads to progressive
renal cyst formation and loss of kidney function in most patients. Vasopressin 2 receptor …

The CRISP study of polycystic kidney disease (PKD) found that urinary sodium excretion
associated with the rate of total kidney volume increase. Whether sodium restriction slows …